MRK eyes on $80.36/74: Double Golden zone break to end DownTrendMRK and all pharma has been dropping forever.
Just pierced the Double Golden zone yet again.
Break and Hold of this zone will say "bottom".
.
Key facts today
11,937.50
0.00 BRL
92.28 B BRL
344.88 B BRL
About Merck & Company, Inc.
Sector
Industry
CEO
Robert M. Davis
Website
Headquarters
Rahway
Founded
1891
ISIN
BRMRCKBDR003
FIGI
BBG0019P2RN5
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Related stocks
MRK - Retesting BreakoutAfter being in a downtrend for almost a year things finally look like they are starting to turn around for MRK.
Recently price broke the downwards sloping resistance and has retested that level as a new support level. We have also seen strength increasing on our daily RSI bringing some life back i
MRK Buying Opportunity!MRK is currently undervalued. The stock price dropped approximately 45% from June 25th of last year to May 15th of this year. At present, the price has bounced off a long-term weekly trendline that has been respected since 2009, indicating a strong rejection zone.
Additionally, on the daily timefra
MRK Wave Analysis – 14 July 2025- MRK reversed from the support zone
- Likely to rise to resistance level 85.00
MRK recently reversed up from the support zone surrounding the long-term support level 73.45 (which has been reversing the price from the start of 2020, as can be seen from the weekly MRK chart below).
The upward rever
Long $MRK- NYSE:MRK is a quality compounder selling at a discount.
Year | 2025 | 2026 | 2027 | 2028
EPS | 8.90 | 9.72 | 10.65 | 10.38
EPS% | 18.36% | 9.21% | 9.54% | -2.52%
Conservative forward p/e should be 10
Fair Stock value:
EPS | 8.90 | 9.72 | 10.65 | 10.38
Price | 89 | 97 | 106 | 103
Positive
MRKEntry Zone: $81.50 to $80.00 (Potential accumulation area for buyers).
Key levels within this zone: $81.51, $81.53, $80.57.
Immediate Resistance: $83.07 (today’s high).
Higher Targets:
$92.63 - $93.26 (First target zone).
$97.36 - $98.25 (Second target zone).
$100.55 - $101.73 (Major resistanc
AAA - Setup from the bottomInverse head and shoulders pattern on the daily timeframe and if you were to break it down further to 12hr it should be also clear.
Monthly rsi sharply bounced back below an RSI of 30, weekly rsi has been below 30 rsi for multile touches
rsi line and rsi moving average crossover indicating change i
$MRK, Long, TP>15-25%NYSE:MRK , Long, TP>15-25%
Fundamentally the stock is good.
Choose an entry point and do not forget about a protective order if you are trading with leverage.
Don't risk it if you're not sure.
Good luck to everyone.
Merck Wave Analysis – 19 May 2025
- Merck reversed from support area
- Likely to rise to resistance level 80.00
Merck recently reversed up from the support area between the long-term support level 73.35 (which has been reversing the price from the middle of 2020) and the lower weekly Bollinger Band.
The upward reversal from this
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
MRK5002693
Merck & Co., Inc. 2.45% 24-JUN-2050Yield to maturity
7.35%
Maturity date
Jun 24, 2050
MRK5319197
Merck & Co., Inc. 2.9% 10-DEC-2061Yield to maturity
7.24%
Maturity date
Dec 10, 2061
US58933YBF1
MERCK & CO. 21/51Yield to maturity
7.15%
Maturity date
Dec 10, 2051
US58933YBA2
MERCK & CO. 20/40Yield to maturity
6.49%
Maturity date
Jun 24, 2040
US58933YAT2
MERCK CO. 2045Yield to maturity
6.37%
Maturity date
Feb 10, 2045
MRK4806294
Merck & Co., Inc. 4.0% 07-MAR-2049Yield to maturity
6.33%
Maturity date
Mar 7, 2049
MRK3900816
Merck & Co., Inc. 3.6% 15-SEP-2042Yield to maturity
6.24%
Maturity date
Sep 15, 2042
US58933YAJ4
MERCK CO. 13/43Yield to maturity
6.09%
Maturity date
May 18, 2043
MRK5584756
Merck & Co., Inc. 5.15% 17-MAY-2063Yield to maturity
6.04%
Maturity date
May 17, 2063
MRK5584755
Merck & Co., Inc. 5.0% 17-MAY-2053Yield to maturity
5.95%
Maturity date
May 17, 2053
MRK5584925
Merck & Co., Inc. 4.9% 17-MAY-2044Yield to maturity
5.82%
Maturity date
May 17, 2044
See all MRCK34 bonds
